Today, Mind Research & Development (www.mindrnd.com) announced a new online healthcare delivery service that enables patients to access medical grade cannabis easily, quickly, discreetly, and professionally. Services are now available for delivery in United States, throughout North America, Europe, and Asia. Mind Research & Development delivers medicine to most patients in 10 days on average.
Patients can register with Mind Research & Development on their website in minutes. After a patient places an order, Mind Research & Development automatically dispatches a professionally packaged package to patients home or office.
The process of acquiring medical grade cannabis from legal California manufacturers during Covid-19 can be slow, cumbersome, and unpredictable. Often patients don’t have access to medical grade cannabis products in their City or Town. Mind Research & Development technology automates everything for patients to have consistent and comfortable experience, while they focus on getting better.
Mind Research & Development seeks to expand quickly while offering their service Globally. The state of California legalized medical cannabis in 1996. The medicine is often used to treat anxiety, epilepsy, cancer, multiple sclerosis, chronic pain and other serious illnesses that may not respond to traditional medications. New medical grade cannabis have been developed to increase healing qualities. Multiple forms of cannabis now exist for non-smokers and children.
Although the healing effects of cannabis have been researched and documented, the medicine is still subject to much controversy. It’s a shame that patients requiring cannabis for anxiety are often stigmatized. At Mind Research & Development we developed technology to make it easier and quicker for patients to receive their medicine through our professional global delivery service.